Berberine and Blood Pressure

What the meta-analyses measured

A 2015 systematic review and meta-analysis pooled 27 randomized controlled trials with 2,569 participants covering type 2 diabetes, hyperlipidemia, and hypertension. In its hypertension subgroups, berberine added to lifestyle intervention tended to lower blood pressure more than lifestyle intervention alone or placebo, and berberine added to an antihypertensive medication tended to lower blood pressure more than that medication alone. The authors emphasized that the overall methodological quality of the included trials was limited, so the apparent benefit could be substantiated only to a limited degree.^[1]

A 2025 systematic review and meta-analysis took a stricter approach, restricting itself to randomized placebo-controlled trials of berberine for components of metabolic syndrome. While berberine significantly reduced triglycerides, fasting plasma glucose, and waist circumference in that analysis, it showed no statistically significant effect on systolic or diastolic blood pressure compared with placebo.^[2]

How to read the mixed results

The two analyses are not directly contradictory once the study designs are considered. The earlier review described a directional tendency toward lower blood pressure when berberine was layered on top of lifestyle changes or existing medication, whereas the newer review isolated berberine against placebo and did not detect a significant blood-pressure change. Taken together, any blood-pressure effect of berberine appears small at most and is not consistently demonstrated in placebo-controlled settings.^{[1], [2]}

Doses studied and tolerability

Berberine was given orally in these trials, used alone, alongside lifestyle measures, or combined with blood-pressure medication, with the daily amounts varying across studies. Across the pooled randomized trials, berberine was generally well tolerated: the 2015 review reported no serious adverse reactions, and the 2025 placebo-controlled review found a safety profile comparable to placebo. These observations reflect group-level trial reporting rather than long-term safety or safety for any specific person.^[1]

Limitations

The earlier meta-analysis drew on trials the authors judged to be of limited methodological quality, and several of its blood-pressure comparisons reflected berberine as an add-on rather than a standalone intervention. The more rigorous placebo-controlled meta-analysis found no significant blood-pressure effect, and its authors called for more high-quality randomized trials. Doses, durations, and participant populations varied across the included studies, so these pooled findings should not be read as a defined blood-pressure regimen or as medical advice.^{[1], [2]}